Showing results (31-40 of 458) with videos related to
Sort By:
Pageof 46
Obstetrics and Gynecology|April 2, 2008
An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS)Philip E Castle, J Thomas Cox, Jose Jeronimo, et al.American Journal of Epidemiology|July 12, 2013
Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatmentAna Cecilia Rodríguez, Diane Solomon, Rolando Herrero, et al.Obstetrics and Gynecology|August 2, 2006
Number of cervical biopsies and sensitivity of colposcopyJulia C Gage, Vivien W Hanson, Kim Abbey, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 diseaseAimée R Kreimer, Richard S Guido, Diane Solomon, et al.Cancer|May 10, 2007
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingMark SchiffmanJournal of the National Cancer Institute. Monographs|June 17, 2003
Chapter 14: Role of triage testing in cervical cancer screeningDiane SolomonJournal of the National Cancer Institute|January 19, 2006
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam, Jane J Kim, William F Lawrence, et al.Journal of Lower Genital Tract Disease|March 23, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.Obstetrics and Gynecology|May 3, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.BMJ (Clinical Research Ed.)|March 4, 2010
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trialsSholom Wacholder, Bingshu Eric Chen, Allen Wilcox, et al.Pageof 46